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The epithelial Na channel (ENaC), composed of three
subunits (), is expressed in various Na-absorbing
epithelia and plays a critical role in salt and water bal-
ance and in the regulation of blood pressure. By using
patch clamp techniques, we have examined the effect of
cytosolic ATP on the activity of the rat ENaC
(rENaC) stably expressed in NIH-3T3 cells and in Madin-
Darby canine kidney epithelial cells. The inward whole-
cell current attributable to rENaC activity ran down
when these cells were dialyzed with an ATP-free pipette
solution in the conventional whole-cell voltage-clamp-
ing technique. This run down was prevented by 2 mM
ATP (but not by AMP or ADP) in the pipette solution or
by the poorly or non-hydrolyzable analogues of ATP
(adenosine 5-O-(thiotriphosphate) and adenosine 5-
(,-imino)triphosphate) in both cell lines, suggesting
that protection from run down was mediated through
non-hydrolytic nucleotide binding. Accordingly, we
demonstrate binding of ATP (but not AMP) to rENaC
expressed in Madin-Darby canine kidney cells, which
was inhibited upon mutation of the two putative nucle-
otide-binding motifs of rENaC. Single channel analyses
indicated that the run down of currents observed in the
whole-cell recording was attributable to run down of
channel activity, defined as NPo (the product of the
number of channels and open probability). We propose
that this novel ATP regulation of ENaC may be, at least
in part, involved in the fine-tuning of ENaC activity
under physiologic and pathophysiologic conditions.
The amiloride-sensitive epithelial Na channel (ENaC)1 reg-
ulates a variety of physiological functions in different Na-
transporting epithelia, such as those in the distal nephron,
distal colon, lung epithelia, and duct cells of exocrine glands (1).
ENaC is composed of three partially homologous subunits, , ,
and  (2, 3). The physiological importance of ENaC has been
underscored by the recent identification of either loss of func-
tion mutations in the channel leading to pseudohypoaldoste-
ronism (PHA1) (4–6) or gain of function mutations causing
pseudoaldosteronism (Liddle’s syndrome), a hereditary form of
arterial hypertension (7–9). Moreover, abnormally high ENaC
activity has been associated with cystic fibrosis due to loss of
the normal inhibitory effect of CFTR on ENaC (10–13), and
gene targeting of ENaC in mice led to newborn death from
pulmonary edema (14).
The activity of ENaC is tightly regulated not only by various
hormones such as aldosterone and vasopressin but also by
intracellular factors via mechanisms that are not yet fully
understood (1). A mechanism by which the activity of ENaC is
regulated in native Na-transporting epithelia is called the
“feedback inhibition,” which is defined as channel down-regu-
lation due to the transport of Na across the apical membrane
and its accumulation intracellularly (1). This mechanism
would allow cells to adjust optimal Na movement across the
apical membrane, thereby protecting themselves from Na
load and the energy consumption required to maintain Na
transport. Previous patch clamp studies in native Na-absorp-
tive epithelia have shown that the feedback inhibition involves
changes in intracellular factors, including membrane potential,
cytosolic pH, Ca2, and Na concentrations, and cell metabo-
lism (1). Furthermore, in recent studies using both molecular
biological and electrophysiological techniques, cytosolic pH,
Na, and/or Ca2 concentration have been also shown to affect
the activity of the cloned rENaC when expressed in different
heterologous expression systems (15–20), although these cyto-
solic factors may not act on the ENaC protein directly (18).
Focusing on the relationship between cell metabolism and
Na channel activity, Palmer et al. (21) and Garty et al. (22)
observed that inhibition of cell metabolism decreased the apical
membrane Na permeability in the toad urinary bladder, al-
though it is not known whether metabolites such as ATP were
responsible for this effect. Frindt et al. (23) also suggested a
role for metabolic changes in mediating negative feedback reg-
ulation of amiloride-sensitive Na channels in rat cortical col-
lecting tubules; they found that increasing Na entry into cells
by the addition of cAMP led to a decrease in channel activity in
cell-attached patches, where the channels were apparently pro-
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tected from the stimulatory effects of the nucleotide, and that
inhibition of the Na-K-ATPase by ouabain prevented the
inhibition of channel activity. The authors concluded that ac-
cumulation or depletion of metabolic substrates could play at
least a partial role in regulating Na channels, especially dur-
ing times of metabolic stress. In accord, an earlier study had
demonstrated decreased amiloride-sensitive Na transport
across bronchial epithelia following metabolic poisoning, which
presumably caused ATP depletion (24). Recently, Chraı̈bi et al.
(25) have identified a novel N-terminal splice variant, which
deletes 49 amino acids in the N-terminal region of the ENaC.
When co-expressed with the - and ENaC subunits in Xeno-
pus oocytes, the corresponding N-terminal deletion mutant of
the ENaC produces significantly smaller amiloride-sensitive
Na currents than those with the wild type subunit. This
smaller current was most likely attributable to a decrease in
the overall open probability of active channels but not in single
channel conductance or in surface expression of the channel
(25). Because the N-terminal region contains a consensus nu-
cleotide-binding motif (GXGXG motif), these observations to-
gether with those on native tissues have led us to hypothesize
that a direct binding of cytosolic nucleotides such as ATP to the
ENaC may be involved in a regulation of the channel activity.
By using patch clamp techniques, we have shown here for
the first time that rENaC heterologously expressed in both
NIH-3T3 fibroblasts and MDCK epithelial cells are regulated
by cytosolic ATP, which is likely mediated by non-hydrolyzable
nucleotide binding to rENaC itself (most likely directly) rather
than by a hydrolytic mechanism.
EXPERIMENTAL PROCEDURES
rENaC Expressing NIH-3T3 and MDCK Cells—NIH-3T3 fibroblasts
(3T3 cells) expressing heterologous rat ENaC (rENaC, untagged)
were previously generated by stably transfecting cells with a retrovirus
expression vector (10). MDCK cells ectopically expressing untagged
rENaC were described previously (10, 16). MDCK cells stably express-
ing HA-tagged rENaC were described earlier (26), and those express-
ing all-tagged ENaC (HAmyc.TFLAG-ENaC) have been described re-
cently (27). Mutant HA-tagged rENaC (2NB) bearing Gly to Ala
mutations in all glycines of the 2 putative nucleotide-binding motifs
(GLGKG3ALAKA at the N terminus, and GRGARG3ARAARA at the
C terminus) was generated using a QuickChange mutagenesis kit
(Stratagene). The HA-rENaC(2NB) mutant was then stably trans-
fected into MDCK cells, as described earlier for the HA-rENaC(WT)
cell line (26). Expression of the untagged ENaC subunits was confirmed
by immunoprecipitation of the metabolically labeled channel using
antibodies directed against each subunit (10)2 and of the tagged ENaC
was confirmed using the appropriate anti-tag antibodies in a Western
blot. Cells were maintained in Dulbecco’s modified Eagle’s medium with
10% fetal bovine serum, penicillin (100 units/ml), streptomycin (100
g/ml), G418 (0.3 mg/ml), and amiloride (10 M) as described elsewhere
(10, 16, 26) (and with hygromycin (100 g/ml)  puromycin (5 g/ml) for
the all-tagged ENaC (HAmyc.TFlag-ENaC) expressing MDCK cells).
For patch clamp experiments, cells were seeded at low density on a
cover glass, grown for 2–4 days. The 3T3 cells were induced with 2 mM
butyrate (overnight), and the untagged rENaC-expressing MDCK cells
with 1 M dexamethasone and 2 mM butyrate (overnight) prior to
patching, as described previously (10, 16). For binding experiments, the
HA-tagged rENaC-expressing MDCK cells were induced with 1 M
dexamethasone (overnight) and the all-tagged rENaC-expressing
MDCK cells with 1 M dexamethasone and 2 mM butyrate (overnight)
prior to the experiments.
Patch Clamp Analyses—Cells grown on cover glass were rinsed with
an appropriate NaCl-rich bath solution (see below), and then were
transferred to a chamber mounted on an inverted microscope. Current
recordings were made from 3T3 cells and MDCK cells using the stand-
ard whole-cell configuration of the patch clamp technique (28). The
patch clamp pipettes, which were pulled from glass capillaries (LG16,
Dagan, Minneapolis, MN) using a horizontal puller (model P-97, Sutter
Instrument, San Rafael, CA) or a vertical puller (model PP-830, Nar-
ishige, Tokyo, Japan), had resistances of 2–3 megohms when filled
with a standard cesium glutamate-rich solution described below.
An Axopatch-1D patch clamp amplifier (Axon Instruments, Union
City, CA) was used to measure whole-cell and single channel currents.
The reference electrode was Ag/AgCl electrode, which was connected to
the bath via an agar bridge (10 mg/ml) filled with a NaCl-rich bathing
solution. The amplifier was driven by pClamp 6 software to allow the
delivery of voltage step protocols with concomitant digitization of the
whole-cell currents. The whole-cell currents were filtered through an
internal four-pole Bessel filter at 1 kHz and sampled at 2 kHz.
Current-voltage (I-V) relations were studied using 10-mV voltage
pulses, each of 400-ms duration, delivered at voltages ranging between
180 and 50 mV, and voltage pulses were separated by 3–10 s during
which the cell potential was held at either 40 or 0 mV. Steady-state
whole-cell currents were measured at 350 ms from the start of each
voltage pulse. For kinetic analysis of the amiloride-sensitive whole-cell
currents, most relaxations were fitted with a single exponential using a
least squares method as described elsewhere (16).
As an alternative to voltage steps, voltage ramps were applied in the
whole-cell experiments where the time course of changes in the current
was examined. Typically, the command voltage was varied from 180
to 0 mV or from 140 to either 0 or 40 mV over a duration of 800 ms
every 10 or 30 s as described in the text. We used this protocol to
monitor rENaC activity because it was easily possible to identify any
appearance of other conductances. Subsequently, we used two criteria
to reject cells as having an abnormally large leakage conductance after
whole-cell dialysis: (i) linear instantaneous I-V relation, and (ii) the
reversal potential of the current was close to zero. In experiments with
MDCK cells, the command voltage was varied from 100 to 20 mV
over a duration of 400 ms every 30 s. Amiloride-sensitive currents were
estimated under each condition by subtraction of currents measured
under identical conditions except for the addition of 10 M amiloride.
The capacitance transient current in most experiments was compen-
sated by using the Axopatch-1D amplifier. The cell capacitance was
42.6  1.2 pF (n  222). The series resistance (Rs) in these studies,
which was 11.9  0.4 megohms (n  222), was not compensated. The
pipette potential was corrected for the liquid junction potentials be-
tween the pipette solution and the external solution and between the
external solution and the agar bridge, as described by Barry and Lynch
(29).
Single channel activity was recorded in the outside-out patch config-
uration (28). By convention, for outside-out patches, the intracellular
potential corresponds to the pipette potential, and downward single
channel currents (carried by Li in the present study) correspond to Li
flux from the extracellular to the intracellular side of the membrane.
Single channel currents were filtered at 50–100 Hz with an internal
four-pole Bessel filter, sampled at 1–2 kHz, and stored directly into the
computer’s hard disk through the TL-1 DMA interface or Digidata 1200
interface (Axon Instruments, Foster City, CA). Subsequent current
analysis was performed using programs supplied with both pClamp 6
and Axograph 3 softwares (Axon Instruments). Because all patches
studied in the present study contained multiple channels (up to several
tens of channels), we calculated the NPo product (N  number of
channels, Po  open probability) as : NPo  IENaC/i where IENaC is the
current resulting from ENaC ( total current minus current with no
channel open, which was evaluated in the presence of 10 M amiloride
in the external solution) averaged over a recording period (every 0.5
min), divided by the unitary current (i) measured as the peak-to-peak
intervals in the amplitude histogram or estimated as the mean of each
current transition. This product could be calculated without making
any assumptions about the total N in a patch or the Po of a single
channel. In our preliminary experiments, we could not routinely ob-
serve reliable channel activities in excised inside-out patches from 3T3
cells; hence, single channel recording using this configuration was
not pursued.
The composition of the standard pipette and bath solutions was as
follows. The pipette solution (pH 7.4) contained (in mM) cesium gluta-
mate (100 or 120), CsCl (10), MgCl2 (1), HEPES (10), EGTA (1 or 10),
and adenosine nucleotide (Na2-ATP) (0–10). In some experiments, ATP
was replaced by equimolar ATP analogues (ATPS or AMP-PNP) or by
other nucleotides (UTP, GTP, AMP, and ADP). The pH of the solution
was adjusted with CsOH at pH 7.4. The cells were initially immersed in
a bath solution (pH 7.4) containing (in mM): NaCl (140), KCl (4.3),
MgCl2 (1), and HEPES (10). Before the establishment of whole-cell
configuration, the bath solution was changed to the one (pH 7.4) con-
taining (in mM) sodium glutamate, lithium glutamate, or potassium
glutamate (145), MgCl2 (1), and HEPES (10). The pH of the solution was
adjusted with NaOH, LiOH, or KOH, respectively. All chemicals were of2 O. Staub and D. Rotin, unpublished data.
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reagent grade and were obtained from Sigma.
All experiments were performed at room temperature (20–23 °C).
Bath solution changes were accomplished by gravity feed from reser-
voirs. The results were reported as means  S.E. of several experiments
(n), and n refers to the number of cells patched in the different plate.
Statistical significance was evaluated by using the two-tailed paired
and unpaired Student’s t test. A value of p  0.05 was considered
significant.
ATP-binding Experiments—For binding (pull down) experiments,
MDCK cells expressing HA-rENaC (WT or the 2NB mutant) or
all-tagged rENaC (HAmyc.TFlag-ENaC) were induced to express the
ENaC subunits overnight and then lysed in lysis buffer (50 mM HEPES,
pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 0.5 or 1% Triton
X-100, 2 mM phenylmethylsulfonyl fluoride, 20 g/ml of each aprotinin,
leupeptin, and pepstatin A). Lysates were then diluted in phosphate-
buffered saline (containing also 1 mM phenylmethylsulfonyl fluoride, 10
g/ml each of aprotinin, leupeptin, and pepstatin A, 5 mM EDTA, and
0.5 mM NaVO4) to reduce Triton X-100 concentration to 0.15–0.20%.
Equal concentrations (unless otherwise indicated) of ATP or AMP con-
jugated to agarose beads (Sigma) were then incubated with the diluted
lysate for 1.5 h (4 °C) and then beads washed (3 times) with HNTG (20
mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol,)
and phosphate-buffered saline (1 time). Proteins were then separated
on a 7 or 10% SDS-PAGE and immunoblotted with anti-HA antibodies
to detect rENaC.
RESULTS
Electrophysiological Properties of rENaC Heterologously Ex-
pressed in NIH-3T3 Cells—A previous study has shown that
rENaC-expressing 3T3 cells, but not untransfected 3T3
cells, exhibit an amiloride-sensitive conductance (10, 11). By
using the conventional whole-cell configuration with the stand-
ard cesium glutamate-rich pipette solution containing 2 mM
ATP and lithium glutamate-rich bath solution, we first char-
acterized in detail amiloride-sensitive macroscopic currents
mediated by rENaC in this heterologous expression system.
Fig. 1A-c shows the traces of the amiloride-sensitive whole-cell
current obtained by digitally subtracting the whole-cell cur-
rents recorded in the presence of amiloride (10 M) (Fig. 1A-b)
from those in its absence (Fig. 1A-a) and indicates that an
activation of the whole-cell current associated with membrane
hyperpolarization was truly mediated by amiloride-sensitive
conductance. Although the activation time constant did not
change significantly at voltages between 184 and 104 mV
(Fig. 1B: the values at 184 and 104 mV were 105.7  13.9
ms (n  11) and 114.4  22.4 ms (n  10), respectively), the
relative amiloride-sensitive current amplitude was slightly
voltage-dependent, so that the relative value was 1.37  0.09
(n  11) at 184 mV and 1.18  0.06 (n  10) at 104 mV (p 
0.002) (Fig. 1C).
We next examined the relative conductance sequence for
various cations of the whole-cell currents. In these experi-
ments, whole-cell currents were recorded in the presence of 150
mM Na, K, or Li as the glutamate salt in the bathing
solution. Fig. 1D summarizes these results. When the amilo-
ride-sensitive Li and Na or Li and K currents were meas-
ured in the same cells, the corresponding currents at a com-
mand voltage of 100 mV were 1.54  0.33 nA (n  8) and
0.81  0.17 nA (n  8) or 1.35  0.20 nA (n  9) and 0.05 
0.03 nA (n  9), respectively. The ratio of the amiloride-sensi-
tive K or Na to Li current at 100 mV was calculated to be
0.04  0.02 (n  9) or 0.55  0.07 (n  8). These results
indicate that the amiloride-sensitive conductance is permeable
to Li and Na but not to K.
We also characterized single channel conductance of rENaC
expressed in NIH-3T3 cells in outside-out patches, which could
be responsible for the amiloride-sensitive whole-cell currents.
The patch pipette was filled with a cesium glutamate solution,
and the bath contained lithium glutamate-rich solution as in
the whole-cell experiments. Fig. 2A shows an example of such
experiments, demonstrating the presence of amiloride-sensi-
tive single channel currents in an outside-out patch. In this
patch, single channel current transitions with up to seven open
levels could be observed, and application of amiloride (10 M)
reversibly abolished channel activity. Under these conditions,
the single channel conductance for Li or Na was estimated to
be 7.9  0.5 pS (n  8) or 3.9  0.1 pS (n  3), respectively.
Consistent with the whole-cell experiments, we could not detect
any current transition when K was substituted for Li (n  7,
data not shown) in the presence of 1 or 10 mM BaCl2 in the bath
solution. We also verified that the blocker did not affect the
single channel conductance when Li was used as a charge
carrier (data not shown).
In single channel experiments, we also confirmed the obser-
FIG. 1. Voltage dependence of whole-cell Li conductance in
rENaC-expressing NIH-3T3 cells. A, an example of tracings of the
whole-cell currents before (a) and after (b) the addition of amiloride (10
M) to the bath solution. c, tracings of amiloride-sensitive currents
obtained from a and b. Hyperpolarizing and depolarizing pulses 400 ms
in duration were applied from a holding potential of 44 mV to poten-
tials between 184 and 46 mV in 10-mV intervals. The pipette was
filled with a cesium glutamate-rich solution. Dependence of the relax-
ation time constant (B) and amiloride-sensitive current amplitude rel-
ative to that at 44 mV (C) on the membrane potential estimated from
the whole-cell Li current induced by voltage pulses from a resting
potential of 44 mV. The relative amiloride-sensitive current ampli-
tude is defined as described under “Experimental Procedures.” Each
point represents the mean  S.E. of 3–11 experiments. D, comparison
of amiloride (10 M)-sensitive Li, Na, and K currents in rENaC-
expressing NIH-3T3 cells. Whole-cell currents were recorded in the
presence of 150 mM Na, Li, or K as the glutamate salt in the bathing
solution. Amiloride-sensitive K currents were measured in the pres-
ence of 1 mM BaCl2 in the bath solution containing 150 mM K
, because
the cells exhibited a large inward whole-cell K conductance. The
blocker had little, if any, effect on ENaC activity when Li was used as
a charge carrier (data not shown). The amiloride-sensitive Na and Li
currents were measured in the same cells. Data are the mean  S.E. of
8 or 9 experiments.
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vation in the whole-cell patch clamp experiments (Fig. 1), dem-
onstrating that channel activity is increased upon membrane
hyperpolarization. Fig. 2, B and C, shows an example of such
experiments and a summary of the results of 7 different exper-
iments, respectively. Although the absolute value of NPo was
variable between each experiment, it was consistently in-
creased upon membrane hyperpolarization (Fig. 2C). When
NPo value was normalized to a value of 1 at 24 mV, the
relative NPo was 2.54  0.68 (n  6) (p  0.01) at 84 mV.
Together, these results extend previous electrophysiological
characterizations of rENaC stably expressed in 3T3 cells (10,
11) and show that the biophysical properties of the macroscopic
and microscopic currents attributable to the activity of rENaC
expressed in these cells were similar to those observed in na-
tive Na-transporting epithelia, such as rat cortical collecting
tubule (1) and other heterologous expression systems such as
Xenopus oocytes and MDCK cells (3, 16, 30).
Run Down of Whole-cell Na Conductance in rENaC-express-
ing 3T3 Cells—In the course of our experiments, we noticed
that the whole-cell currents attributable to rENaC activity
exhibited a run down when the cells were dialyzed with a
standard cesium glutamate-rich solution with no ATP. We first
realized this phenomenon due to the small amiloride-sensitive
whole-cell conductance detected in 3T3 cells expressing rENaC.
Because in our initial experiments the measurement of whole-
cell currents was started at least a few minutes after whole-cell
dialysis, we thus performed a systematic time course experi-
ment to examine if the Na channel activity would run down
during whole-cell dialysis. An example of such experiments is
shown in Fig. 3A. Ramp command voltages were applied be-
tween 184 and 4 mV from a holding potential of 44 mV
every 10 s. As shown in the figure, the inward whole-cell
currents ran down and reached a steady-state level within 3
min. A residual whole-cell conductance was still completely
amiloride-sensitive (Fig. 3B), and the whole-cell Li conduct-
ance was greater than that of Na (Fig. 3C). Furthermore, an
activation of the whole-cell current was also observed when the
membrane was strongly hyperpolarized (data not shown). We
also confirmed in other sets of experiments that most of the
inward currents under these conditions were amiloride-sensitive
in cells that fulfilled the following criteria: (i) an inwardly recti-
fying instantaneous I-V relation, and (ii) an extrapolated reversal
potential of the current was far from zero (usually greater than
30 mV). Under these conditions, total inward current at 104
mV was 1.92  0.40 nA (n  11). Amiloride-insensitive con-
ductance measured just after whole-cell dialysis was only 13.5 
2.8% (n  11) of the total inward current at 104 mV.
FIG. 2. A, an example of single channel activity recorded in an out-
side-out patch from rENaC expressed in 3T3 cells. The patch pipette
was filled with cesium glutamate solution and the bath contained
lithium glutamate-rich solution. Application of amiloride (10 M), the
period of which is indicated by thick bar, to the bath solution abolished
channel activity. The top trace shows the time course of the amiloride
effects. Three parts of the trace (1–3) are extended to display details of
the channel activity. Holding potential was 24 mV. B, voltage depend-
ence of single channel activity in outside-out patches. Tracings of a
single channel inward current obtained from an outside-out patch. The
channel activity defined as NPo at a holding potential of 4, 24, and
64 mV were 1.54, 2.14, and 3.29, respectively. C, summary of 7
different experiments where NPo was determined at various membrane
potentials. Lines connect data obtained from the same patch. The patch
pipette was filled with cesium glutamate solution, and the bath con-
tained lithium glutamate-rich solution.
FIG. 3. A, an example of run down of the whole-cell inward current in
3T3 cells expressing rENaC. Ramp voltages were applied from 183 to
3 mV every 10 s. The holding potential was 43 mV. The pipette was
filled with a cesium glutamate-rich solution with no ATP, and the bath
solution contained sodium glutamate solution. Effects of amiloride (10
M) (B) and replacement of 150 mM Na with an equimolar Li or
NMDG (C) in the bath solution on the residual currents after run
down. Data were obtained from the same cell shown in A. D, summary
of time course of changes in the inward current amplitude at 104 mV.
The current amplitude was normalized to 1 with the initial measure-
ments. Data represent the mean  S.E. of 5 experiments. The patch
pipette was filled with cesium glutamate solution (1 mM EGTA) with no
ATP, and the bath contained sodium or lithium glutamate-rich solution.
E, effects of increasing EGTA concentration to 10 mM in the pipette
solution on the inward current at 104 mV. Currents were elicited by
800-ms voltage ramp between 144 and 4 mV from a holding poten-
tial of 44 mV every 30 s. The current amplitude was normalized to 1
with the initial measurements. Data represent the mean  S.E. of 11
experiments. The patch pipette was filled with cesium glutamate solu-
tion (1 mM EGTA) with no ATP, and the bath contained a lithium
glutamate-rich solution. F, effects of addition of ATP (2 mM) to the
pipette solution on the inward current at 104 mV. Experimental
protocol was same as in E. The current amplitude was normalized to 1
with the initial measurements. Data represent the mean  S.E. of 5
experiments.
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Fig. 3D shows the time course of run down of the inward
current amplitude at 104 mV, which was normalized to the
value at the initial measurement made within a few tens of
seconds of formation of the whole-cell configuration. The nor-
malized current amplitude within 3 min after whole-cell dial-
ysis was decreased to 49.0  8.6% (n  5). These results
suggest that activity of rENaC expressed in 3T3 cells runs
down after whole-cell dialysis using a pipette solution contain-
ing no ATP.
Because it has been shown that an increase in cytosolic Ca2
concentrations inhibits the activity of rENaC heterologously
expressed in MDCK cells (16) and in Xenopus oocytes (19), we
examined the possibility that cytosolic Ca2 levels had not been
clamped at a low enough concentration in 3T3 cells under the
present experimental condition. We thus increased the concen-
tration of EGTA in the pipette solution containing no ATP from
1 to 10 mM. As shown in Fig. 3E, however, there was little if any
difference in the time course of run down between these two
experimental conditions, so that the normalized current ampli-
tude within 5 min after whole-cell dialysis was decreased to
44.3  8.7% (n  11). These results suggest that cytosolic Ca2
does not play a role in the run down of rENaC.
Inclusion of ATP in the Pipette Solution Prevents Run Down
of the rENaC Current—We next examined the effect of inclu-
sion of ATP in the pipette solution. When 2 mM ATP was added
to the pipette solution, the cells exhibited a stable whole-cell
inward current even after 5 min of whole-cell dialysis (Fig. 3F).
In order to characterize the ATP dependence of the run down,
we performed other sets of experiments where cells were dia-
lyzed with a pipette solution containing different concentra-
tions of ATP (0–10 mM) (Fig. 4). To assess quantitatively the
relationship between ATP concentration in the pipette solution
and the run down, we measured the amiloride-insensitive in-
ward current at the end of the experiments and subtracted it
from the inward current. In separate experiments, we also
ensured that the amiloride-insensitive current was stable dur-
ing the experiments, so that the normalized amiloride-insensi-
tive current amplitude 5 min after dialysis was 118.5  14.3%
(n  7) of the initial level of the amiloride-insensitive current
amplitude at 104 mV. The time-dependent decrease in in-
ward current was dependent on the concentration of ATP in the
pipette solution. The normalized current amplitude 5 min after
whole-cell dialysis was 99.6  7.1% (n  13) of the initial level
of the amiloride-sensitive current, which was significantly dif-
ferent from that observed with ATP-free solution (64.5  3.4%
(n  16) (p  0.0003). With ATP present in the pipette at 0.1 or
0.3 mM, inward current ran down and the current amplitude at
104 mV decreased to 70.1  5.3 (n  18) or 85.4  4.3% (n 
13) of the initial amiloride-sensitive current level 5–6 min after
dialysis of the cells. In contrast, at a concentration of 10 mM
ATP, the inward current was stable after whole-cell dialysis, so
that the normalized current amplitude at 104 mV was
102.0  4.3% (n  17). When the current amplitude (normal-
ized to the initial level 5 min after whole-cell dialysis) was
plotted against the pipette ATP concentrations, the Kd value
was estimated to be 0.31 mM (Fig. 4). These results suggest
that cytosolic ATP affects the activity of ENaC.
ATP Hydrolysis Is Not Required for the Effect of ATP—
Prevention of the run down by ATP observed in the whole-cell
recordings could have at least two explanations. One is the
modulation of ENaC function by protein kinases and/or
through ATP hydrolysis as shown in the cystic fibrosis trans-
membrane regulator (CFTR). The other is modulation of ENaC
activity through non-hydrolytic ATP binding to the channel
itself or to an associated protein, as seen in other types of
channels and transporters (31, 32). To distinguish between
these two possibilities, we first examined the effect of removal
of Mg2 from the pipette solution on the inward current am-
plitude, because both protein kinases and ATPases require
ATP with Mg2 as a substrate. In the presence of 10 mM ATP,
with or without Mg2 (Fig. 5, A and B), the inward current did
not run down, and the normalized inward current amplitude
was 116.6  16.2% (n  8) of the initial level 5 min after
dialysis (Fig. 5B). To ensure that free Mg2 concentration in
the cytosol was clamped to a low level after whole-cell dialysis,
we further included 10 mM EDTA in the pipette solution con-
taining no Mg2 (Fig. 5C). Under these conditions, the whole-
cell current was stable during the experiments, so that the
normalized inward current amplitude 5 min after whole-cell
dialysis was 105.0  1.2% (n  3) of the initial level.
We next investigated the effect of a poorly hydrolyzable ATP
analogue, ATPS (2 mM), and a non-hydrolyzable ATP ana-
logue, AMP-PNP (2 mM). ATPS or AMP-PNP (2 mM) were both
effective at preventing the run down, and the normalized in-
ward current amplitude at 104 mV was 94.2  8.6 (n  6) or
108.2  15.0% (n  10) of the initial level, respectively (Fig. 5,
D and E). Taken together, these results are compatible with the
notion that ENaC activity may be regulated by ATP through
non-hydrolytic binding.
Effects of Other Nucleotides—To investigate the specificity of
inhibition of rENaC run down by nucleotides, we examined the
effect of dialyzing the cells with a pipette solution containing 2
mM AMP. A representative example of an experiment involving
dialysis with 2 mM AMP is depicted in Fig. 6A, showing that
AMP was unable to prevent the run down (normalized amilo-
ride-sensitive current amplitude at 104 mV was 56.9  5.2%
(n  14) of the initial level 5 min after onset of dialysis) (Fig.
6B). Likewise, ADP did not prevent the run down nor did 2 mM
GTP or UTP (normalized amiloride-sensitive current ampli-
tudes at 104 mV after 5 min of dialysis were 72.9  2.6 (n 
FIG. 4. The effect of different concentrations of ATP (0–10 mM)
in the pipette solution on the run down of the amiloride-sensi-
tive currents. Currents were elicited by 800-ms voltage ramp between
144 or 184 mV and 4 mV from 3T3 cells expressing rENaC. For
comparison, the amiloride-sensitive current values 5 min after whole-
cell dialysis were normalized to those measured at 0 min at 104 mV.
Initial amiloride-sensitive current at 104 mV was 1.38  0.27 nA
(n  16), 1.66  0.24 nA (n  18), 1.78  0.32 nA (n  13), 1.54 
0.24 nA (n  14), or 1.30  0.14 nA (n  17) when the cells were
dialyzed with a pipette solution containing 0, 0.1, 0.3, 2, or 10 mM ATP,
respectively. Shown are mean  S.E.
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14), 71.7  4.9 (n  19), or 61.2  4.7% (n  14), respectively)
(Fig. 6C).
Effects of Cytosolic ATP on the Voltage-dependent Activation
of rENaC—We showed that rENaC heterologously expressed
in 3T3 cells is activated by membrane hyperpolarization (Fig.
1) as shown in native rat cortical collecting duct cells (33, 34)
and in rENaC heterologously expressed in MDCK (16). We next
examined whether depletion of cytosolic ATP might change the
voltage-dependent activation of rENaC. To do this, we dialyzed
the cells with a pipette solution containing no ATP and com-
pared the results with a voltage-dependent activation seen in
cells dialyzed with 2 mM ATP (shown in Fig. 1). When the cells
were dialyzed with a pipette solution containing no ATP, the
relative amiloride-sensitive current amplitude was also shown
to be slightly voltage-dependent, so that the relative value was
1.43  0.07 (n  7) at 184 mV and 1.19  0.05 (n  7) at 104
mV, respectively. These values were similar to those observed
in the cells dialyzed with a pipette solution containing ATP (2
mM). These results suggest that voltage-dependent activation
is not affected by cytosolic ATP.
Run Down of the Macroscopic rENaC Currents Is Not Asso-
ciated with the Reduction in the Single Channel Conductance of
rENaC—Because whole-cell current can be defined as the prod-
uct of single channel conductance, number of channels (N), and
open probability (Po) of an individual channel, we first exam-
ined the possibility that the single channel conductance might
be decreased upon ATP removal or other nucleotides replace-
ment of ATP in the whole-cell experiments. To do this, we used
an outside-out patch configuration, because under these exper-
imental conditions, both cytosolic and extracellular environ-
ment should be the same as in whole-cell experiments. As
summarized in Table I, there were little, if any, changes in the
single channel conductance between the different experimental
conditions, suggesting that a change in single channel conduct-
ance was not responsible for the results of the whole-cell
experiments.
Run Down of the Macroscopic Currents Is Associated with
Changes in Single Channel Activity of rENaC—We subse-
quently examined the effect of cytosolic ATP on ENaC activity
at the single channel level. We used an outside-out patch con-
figuration to examine directly whether cytosolic ATP concen-
tration would affect the run down of channel activity seen in
the whole-cell experiments described above. In the outside-out
configuration, the identity of the channel could be verified by
the reversible blocking effect of amiloride. This was especially
important in the present study, because the patch membrane
always contained multiple channels (up to several tens of chan-
nels). After the whole-cell configuration was established, out-
side-out patches were made, and channel activity was contin-
uously recorded at a fixed membrane potential ranging from
10 to 50 mV for more than 5 min. Fig. 7 shows two examples
of recording made in outside-out patches, either without ATP
(Fig. 7A) or with 2 mM ATP (Fig. 7B). As evident, channel
activity ran down during the experimental period when the
pipette solution contained no ATP. The time course of changes
in the relative NPo is shown in Fig. 8A. NPo value was normal-
ized to 1 with the value of the initial 30 s. In 12 experiments, we
observed that channel activity (NPo) decreased to 45.5  6.9%
of the initial value within 4 min (Fig. 8B). Similar experiments
were repeated using different concentrations of ATP in the
pipette solution. Fig. 7B represents an example of these exper-
iments, where the cytosolic surface of the membrane was ex-
posed to 2 mM ATP. The time course of changes in the relative
NPo is also shown in Fig. 8A. As seen in these figures, channel
activity was relatively stable during the experiments (NPo of
90.1  9.4% (n  15) of the initial value at 4 min after excision).
When the pipette solution contained a higher concentration of
ATP (10 mM), NPo was 84.2  5.8% (n  10) of the initial value
(Fig. 8A). We also examined the effect of ADP on the stability of
channel activity in excised outside-out patches, and we showed
that cytosolic ADP at 2 mM was unable to prevent channel run
down (NPo of 55.7  12.9 (n  7) of the initial value within 4
min) (Fig. 8B).
Run Down of rENaC Activity in MDCK Cells and Its Preven-
tion by Cytosolic ATP and the Non-hydrolyzable ATP Analogue,
AMP-PNP—Because the 3T3 cells are fibroblasts (which, with
some exceptions (35), do not normally express ENaC), we in-
vestigated whether the ATP-dependent run down observed in
these cells could also be observed in an epithelial cell. To this
end, we used MDCK cells stably transfected with -rENaC,
because (i) these are kidney epithelial cells, (ii) their electro-
physiological properties had been extensively characterized
(16), and (iii) our unpublished work has detected trace amounts
of endogenous ENaC in these cells, suggesting that they pos-
sess the proper cellular environment for ENaC regulation. Al-
though in our previous study (16) we used a conventional
whole-cell patch clamp configuration with an ATP-free pipette
solution, in that earlier study we only characterized the whole-
FIG. 5. Effects of removal of Mg2 from the pipette solution (B) and of
addition of EDTA (10 mM) to the pipette solution with no added Mg2
(C). The control experiments with 1 mM Mg2 is shown in A. The cesium
glutamate-rich pipette solution contained 10 mM ATP and 10 mM
EGTA, and the bath contained lithium glutamate-rich solution. Cur-
rents were elicited by 800-ms voltage ramp between 144 and 4 mV
from a holding potential of 44 mV every 30 s. Data are the mean 
S.E. of 17, 8, or 3 experiments. Effect of the poorly hydrolyzable or the
non-hydrolyzable ATP analogue, ATPS (D) or AMP-PNP (2 mM) (E).
Pipette contained cesium glutamate-rich solution, and the bath con-
tained lithium glutamate-rich solution. Data are the mean  S.E. of 6
or 10 experiments.
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cell currents several minutes after whole-cell dialysis, thus we
likely missed the relatively fast run down in MDCK cells. As
shown in Fig. 9A, when the cells were dialyzed with a cesium
glutamate pipette solution containing no ATP, amiloride-sen-
sitive current ran down. The normalized amiloride-sensitive
current amplitude within 5 min after whole-cell dialysis was
decreased to 54.0  10.2% (n  11) of the initial amiloride-
sensitive current level (Fig. 9C). The run down of the current
was inhibited by dialysis of the cells with a pipette solution
containing 2 mM ATP (92.5  7.4% (n  10)) or 2 mM AMP-PNP
(99.5  13.8% (n  9) (Fig. 9B), but not 2 mM ADP (55.4  6.5%
(n  11)) or 2 mM AMP (53.3  10.1 (n  8)) (Fig. 9C). These
results suggest that the ATP regulation of rENaC is not con-
fined to NIH-3T3 cells expressing ENaC but is also observed in
epithelial cells and thus may represent a more generalized
phenomenon of ENaC regulation in mammalian cells.
Binding of ATP to rENaC—The above results collectively
suggest that ATP may bind rENaC, possibly directly. Because
rENaC, but not - or rENaC, possess two putative nucleoti-
de-binding (NB) sites (GXGXG and GXGXXG at the N and C
termini, respectively), we tested if ATP can bind rENaC. We
thus incubated lysate of MDCK cells stably expressing
rENaC, either alone or together with -rENaC, with immo-
bilized (agarose-conjugated) ATP or AMP (used as a control).
As shown in Fig. 10, the ATP-agarose beads, but not the AMP-
agarose beads, were able to precipitate rENaC from MDCK
cell lysate. Similar results were obtained with several types of
beads conjugated to ATP or AMP via different linkages and
spacer lengths (C-8 attachment, 9 atom spacer; N-6 attach-
ment, 11 atom spacer; ribose attachment, 11 atom spacers)
(Fig. 10 and data not shown). Our preliminary data also indi-
cate that binding of rENaC to ATP-agarose can be competed
off with soluble ATP (not shown). Thus, these results demon-
strate binding of ATP, but not AMP, to rENaC.
To test whether the putative NB motifs in rENaC are
indeed the binding sites for ATP, we generated stable MDCK
cell lines expressing rENaC mutated for both NB sites (Fig.
11A). As can be seen in Fig. 11B, mutating both NB motifs led
to severe inhibition of ATP binding to rENaC, implicating
these motifs as major binding sites for ATP. Residual binding is
still observed, however, in these mutants, suggesting that an-
other minor binding site(s), not yet identified, may be involved
FIG. 6. Effects of different nucleotides on the run down of the amiloride-sensitive currents. A, representative tracings of whole-cell
currents obtained from a rENaC expressing 3T3 cell dialyzed with a pipette solution containing 2 mM AMP. Currents were elicited by 800-ms
voltage ramp between 144 and 4 mV from a holding potential of 44 mV every 30 s. B, time course of changes in amiloride-sensitive current
amplitude at 104 mV from cells dialyzed with a pipette solution containing 2 mM AMP. C, effects of dialysis of the cells with a pipette solution
containing ADP, AMP, GTP, and UTP at 2 mM each. The bath solution was a lithium glutamate-rich solution. For comparison, the amiloride-
sensitive current values 5 min after whole-cell dialysis were normalized to those measured at 0 min at 104 mV. Initial amiloride-sensitive current
at 104 mV was 1.50  0.24 nA (n  16), 1.54  0.24 nA (n  13), 2.05  0.19 nA (n  14), 2.05  0.30 nA (n  14), 1.56  0.22 nA (n 
19), or 1.91  0.25 nA (n  14) when the cells were dialyzed with a solution containing no nucleotides (), 2 mM ATP, 2 mM ADP, 2 mM AMP,
2 mM GTP, or 2 mM UTP, respectively. Shown are mean  S.E.
TABLE I
Summary of single channel conductance obtained in outside-out
patch experiments, where the patch pipette was filled
with test solutions described
Test solutions Single channelconductance
No nucleotide 8.2  0.3 pS (n  12)
ATP (10 mM) 7.9  0.5 pS (n  8)
ATP (10 mM)  10 mM EDTA 8.3  0.6 pS (n  7)
ADP (2 mM) 7.8  0.3 pS (n  6)
ATPS (2 mM) 7.6  0.3 pS (n  3)
AMP-PNP (2 mM) 7.9  0.4 pS (n  5)
UTP (2 mM) 9.2  0.1 pS (n  3)
GTP (2 mM) 8.9  0.2 pS (n  4)
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as well. We have also generated MDCK cell lines expressing
individual NB motifs mutant (i.e. mutated NB motif in either
the N or C terminus of rENaC). Each of these revealed only
partial inhibition of ATP binding (40–60%), suggesting that
both motifs are able to bind ATP under our experimental con-
ditions (data not shown).
DISCUSSION
By using patch clamp techniques, we have shown here that
rENaC heterologously expressed in both NIH-3T3 fibroblasts
and MDCK epithelial cells is regulated by cytosolic ATP. This
regulation is likely mediated by non-hydrolyzable nucleotide
binding to rENaC itself (most likely) or to an accessory protein,
rather than by a hydrolytic mechanism. To our knowledge, this
is the first demonstration of ATP binding to rENaC and of
cytosolic ATP-mediated regulation of rENaC expressed in
mammalian cells.
In the present whole-cell patch clamp studies, we provide
several lines of evidence that the sustained activity of rENaC
expressed in 3T3 cells is dependent upon cytosolic ATP. (i)
Whole-cell dialysis with an ATP-free pipette solution caused a
marked run down of the whole-cell currents attributable to
rENaC activity (Fig. 3). (ii) The run down was prevented when
the pipette solution contained 2 mM ATP (Fig. 3). (iii) ATP
prevented the run down in a dose-dependent manner (Fig. 4).
Furthermore, because other nucleotides including ADP, AMP,
GTP, or UTP at 2 mM were relatively ineffective (Fig. 6), the
sustained activity of the rENaC in 3T3 cells seems to be regu-
lated by ATP itself rather than by other nucleotides. Moreover,
a similar run down of the amiloride-sensitive whole-cell cur-
rents was observed in MDCK cells expressing rENaC, and this
run down was also inhibited by ATP, but not by ADP or AMP
(Fig. 9), arguing against the possibility that ATP regulation of
rENaC in 3T3 cells is a peculiar phenomenon specific to
3T3 cells.
Under the present experimental conditions, the whole-cell
current attributable to rENaC activity ran down and reached a
steady-state level within 4–5 min after onset of whole-cell
dialysis. The time course of the run down should depend upon
the rate of diffusional equilibrium of ATP in 3T3 cells, because
the time course of dialysis between the patch pipette and the
cell interior is a function of cell volume and geometry, access
resistance between the pipette and the cell, and the molecular
weight of the molecules tested (36). Furthermore, in the whole-
cell experiments, the local concentration of ATP in the proxim-
ity to rENaC (or its putative regulatory protein) may not be
exactly the same as in the pipette due to diffusion limitations
and endogenous ATP production and consumption. Therefore,
the present study does not allow us to determine the precise Kd
value of ATP for rENaC activity. Nevertheless, the data are
consistent with the idea that relatively high ATP concentra-
tions, in the millimolar range, are required to maintain maxi-
mal activity of rENaC. This idea is also supported by the
present outside-out patch experiments, demonstrating that cy-
tosolic ATP at millimolar concentrations could prevent the run
down of rENaC activity.
FIG. 7. Stability of rENaC activity in excised outside-out
patches with pipette solution without or with ATP. No ATP (A) or
2 mM ATP (B) was included in the pipette solution, and the bath
solution contained a lithium glutamate-rich solution. As soon as whole-
cell configuration was established, the membrane was excised to make
outside-out patches. Channel activity was continuously recorded at 24
mV for more than 5 min. Application of amiloride (10 M, thick bar) to
the bath solution abolished channel activity. The top trace shows the
time course of the amiloride effect. Three parts of the trace (1–3) are
extended to display the details of the channel activity. Holding potential
was 24 mV.
FIG. 8. A, time course of the changes in the relative channel activity (NPo). NPo value was estimated every 30 s and normalized to 1 with the
initial 30 s. Data were obtained from 12, 15, or 10 experiments. B, summary of the effects of cytosolic ATP and ADP (2 mM) on the stability of
channel activity. Data were obtained from 12, 14, or 7 experiments, respectively.
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The run down of ENaC activity in the conventional whole-cell
experiments has been also reported in cortical collecting tubule
cells freshly isolated from rats maintained on a low sodium diet
(33). These investigators observed that whole-cell dialysis of the
cells caused a rapid fall in whole-cell currents mediated by ENaC
within the first 5 min of their whole-cell recording. Although the
kinetics of the run down seen in these cells was similar to that in
the present study, the underlying mechanism appears to be dif-
ferent, because it was prevented by 0.3 mM GDPS but not by
ATP (3 mM), ADP (3 mM), GTP (0.3 mM), GDP (0.3 mM), or GTPS
(0.3 mM) (34). Currently, we do not have an explanation for the
differences between these results and ours.
As the macroscopic whole-cell conductance mediated by
ENaC is defined as a product of single channel conductance (g),
the number of active channels (N), and open probability (Po),
the run down of the macroscopic conductance should be attrib-
utable to the decrease in these parameters. In excised outside-
out patch experiments, we showed that single channel conduct-
ance was not changed in experiments where the cytosolic
surface of the membrane was exposed to various experimental
solution used in the whole-cell experiments (Table I). These
results suggest that alternation of single channel conductance
FIG. 9. Representative experiments showing the effect of dialysis of
rENaC-expressing MDCK cells with a pipette solution containing either
(A) no nucleotide or (B) 2 mM AMP-PNP on the amiloride-sensitive
currents. The whole-cell current at 104 mV was measured every 0.5
min. Currents were elicited by 400-ms voltage ramp between 104 and
16 mV from a holding potential of 44 mV. C, summary of the effects
of dialysis of rENaC-expressing MDCK cells with a pipette solution
containing either no nucleotide or 2 mM ATP, ADP, AMP, and AMP-
PNP on the amiloride-sensitive currents. Currents were elicited by
400-ms voltage ramp between 104 and 16 mV from a holding poten-
tial of 44 mV. For comparison, the amiloride-sensitive current values
5 min after whole-cell dialysis were normalized to those measured at 0
min at 104 mV. Initial amiloride-sensitive current at 104 mV was
3.07  1.03 nA (n  11), 2.75  0.56 nA (n  10), 4.60  0.44 nA
(n  11), 3.32  0.95 nA (n  8), and 3.32  0.84 nA (n  9) when
the cells were dialyzed with a solution containing no nucleotides, 2 mM
ATP, 2 mM ADP, 2 mM AMP, and 2 mM AMP-PNP, respectively. Shown
are mean  S.E.
FIG. 10. Binding of ATP to rENaC. ATP- or AMP-agarose beads
were incubated with diluted lysate from MDCK cells stably expressing
rat all-tagged ENaC (HAmyc.T Flag-ENaC) (A) or rat HA-rENaC
alone (B). Beads were then extensively washed, and bound protein was
separated on a 7% SDS-PAGE and immunoblotted with anti-HA anti-
bodies to detect rENaC. Lanes 1 and 2 depict untransfected (un-transf)
and ENaC-expressing MDCK cells, respectively. Lanes 3–5 represent
pull down experiments with C-8 attached (9 atom spacer) AMP- or
ATP-agarose beads, where AMP and ATP concentrations are equal (90
nmol in 1.5 ml diluted lysate) in lanes 3 and 5, and 4 times AMP (360
nmol) used in lane 4 (to equate the volume of agarose beads to that of
the agarose-ATP in lane 5). Lanes 6 and 7 represent pull down exper-
iments with equal concentrations of ribose-attached (11 atom spacer)
AMP- or ATP-agarose beads (90 nmol in 1.5 ml., and where beads
volume of the AMP beads was 2.5 times that of the ATP beads). Expo-
sure time of the film in lanes 6 and 7 (in A and B) was longer than in
lanes 3–5. The 70-kDa band seen in lane 1 (untransfected MDCK cell
lysate) is a nonspecific band cross-reacting with the anti-HA antibodies.
FIG. 11. Inhibition of binding of ATP to mutant rENaC lack-
ing both putative nucleotide-binding (NB) sites. A, schematic
representation of the N- and C-terminal NB sites in rENaC and the
mutant bearing Gly 3 Ala mutations in all glycines of the NB sites
(HA-rENaC(2NB)). B, ATP-agarose beads were incubated with di-
luted lysate from MDCK cells either untransfected (un-transf, lane 4) or
stably expressing wild type HA-rENaC (WT) (lanes 6 and 8) or HA-
rENaC(2NB) (lanes 7 and 9). Beads were then extensively washed,
and bound protein was separated on a 10% SDS-PAGE and immuno-
blotted with anti-HA antibodies to detect rENaC. AMP-agarose beads
were also used as controls (lane 5). Lanes 1–3 depict lysates from
untransfected (un-transf), WT, and 2NB mutants cells used for the
experiment. Lanes 6–9 represent duplicate treatments.
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is not involved in the run down of the macroscopic ENaC
currents. Furthermore, in excised outside-out patch experi-
ments, we also found that cytosolic ATP, but not ADP (each at
2 mM), was effective in preventing the run down of channel
activity (Fig. 8). Assuming a fixed number of channels in ex-
cised outside-out patches (as insertion or degradation of ENaC
is unlikely to take place in such excised membranes), these
results suggest that a decrease in the overall open probability
of ENaC present at the membrane may be responsible for the
run down of the macroscopic currents. Therefore, we conclude
that a decrease of the channel activity, defined as NPo, is
responsible for the run down of the macroscopic currents.
Our data are compatible with the hypothesis that the effect
of ATP on ENaC is mediated through non-hydrolytic binding to
ENaC, most likely by association with ENaC, rather than
through ATP hydrolysis and phosphorylation. The hypothesis
is strongly supported by the following observations. (i) ATP was
effective in preventing the run down without Mg2, a cofactor
required for ATP hydrolysis and phosphorylation (Fig. 5). (ii)
The non-hydrolyzable ATP analogues AMP-PNP and ATP-S,
at 2 mM, were able to prevent the run down (Figs. 5 and 9). (iii)
The approximate Kd value of the ATP effect was close to the mM
range (Fig. 4). (iv) Binding experiments using agarose-conju-
gated ATP or AMP beads demonstrated association of ENaC
with ATP but not AMP beads (Fig. 10). In this regard, it is
noteworthy that there are two consensus nucleotide-binding
motifs in rENaC: an N-terminal Gly-X-Gly-X-Gly sequence
found in rENaC as also seen in the Cl channel Icln (37), and
a C-terminal Gly-X-Gly-X-X-Gly motif that is conserved in
ENaC of several species as well as in most protein kinases
(38). Indeed, mutating those motifs in ENaC inhibits ATP
binding (Fig. 11), lending further support to the notion that
ATP directly binds ENaC. At present, however, we do not
know how binding of ATP to ENaC may regulate channel
activity, although we can speculate it may alter channel con-
formation, in some way affecting its activity.
Our data may give an explanation for a previous observation
that when co-expressed with the - and ENaC subunits in
Xenopus oocytes, a splice variant of ENaC lacking 49 amino
acids in the N-terminal region produced a considerably smaller
amiloride-sensitive Na current than wild type, a reduction of
the currents being attributable to a decrease in the overall open
probability of activity channels (25). The 49-amino acid dele-
tion at the N terminus of ENaC removing the ATP-binding
site may lead to reduced ENaC activity (i.e. decreased open
probability), possibly by permanently locking the channel in a
“run down” state, although we cannot exclude the possibility
that other region(s) within these 49 amino acids is (are) also
contributing to the effect. In fact, our experiments on a nucle-
otide-binding motif mutant in the N terminus of ENaC re-
vealed a partial inhibition of ATP binding. Furthermore, the
splice variant, which is shown to be expressed in various tis-
sues expressing the normal ENaC (25), might play a role in
diversity of the regulation of ENaC in native tissues.
Abriel and Horisberger (18) showed that perfusion of the
cytoplasm with or without ATP had no effect on the activity of
rENaC heterologously expressed in Xenopus oocytes using the
“cut open oocyte” technique, leading them to suggest that direct
interactions of ATP and the ENaC protein itself are unlikely.
At this stage, we do not have a simple way to account for the
differences between their results and ours. It may be that an
unknown component(s), washed away by the rigorous intracel-
lular perfusion in the cut open oocyte system, is needed for the
ATP-ENaC association and the ensuing regulation of channel
activity by ATP. Although our results strongly suggest a direct
binding of ATP to ENaC, indirect binding cannot be precluded
at present. In this regard, it is interesting to note a previous
study demonstrating that glibenclamide, a known inhibitor of
ATP-binding cassette proteins, such as CFTR or the sulfonylu-
rea receptor, induced amiloride-sensitive currents in oocytes
expressing human or Xenopus ENaC but not rENaC (39).
These authors suggested the possibility of an existence of an
ATP-binding cassette-type regulatory protein closely associ-
ated with ENaC in Xenopus oocytes
Although the present study was undertaken in heterologous
expression systems (NIH-3T3 fibroblasts and MDCK epithelial
cells), our data clearly suggest that the activity of ENaC can be
under the control of cytosolic ATP in native cells. It has been
shown in tight epithelia that the rate-limiting step for tran-
sepithelial Na absorption is Na entry through ENaC across
the apical membrane, and that Na-K-ATPase adapts its
activity to maintain a low intracellular Na concentration (1).
Taking into account the fact that the Michaelis-Menten con-
stant of the Na-K-ATPase for ATP is very low (40), only a
drastic depletion of ATP would be able to affect this pump. If
regulation of ENaC by intracellular ATP levels was to take
place in native epithelial cells, it would effectively prevent the
overloading of Na in these cells under certain metabolic stress
conditions, in addition to the regulation provided by membrane
potential and by cytosolic Na. Furthermore, assuming cytoso-
lic ATP concentrations in the mM range, the ATP-mediated
regulation of ENaC reported in the present study could be also
important for the fine-tuning of ENaC activity.
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